RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway

被引:0
作者
Kailiang Qiao
Yantao Liu
Zheng Xu
Haohao Zhang
Heng Zhang
Chao Zhang
Zhi Chang
Xinyan Lu
Zhongwei Li
Ce Luo
Yanrong Liu
Cheng Yang
Tao Sun
机构
[1] Nankai University,State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy
[2] Tianjin International Joint Academy of Biomedicine,Tianjin Key Laboratory of Molecular Drug Research
[3] Jining Medical University,Department of Pathology, Affiliated Hospital of Jining Medical University
来源
Angiogenesis | 2021年 / 24卷
关键词
Metastasis; Vasculogenic mimicry; N6-methyladenosine; METTL3; YAP1;
D O I
暂无
中图分类号
学科分类号
摘要
Vasculogenic mimicry (VM) formed by aggressive tumor cells to mimic vasculogenic networks plays an important role in the tumor malignancy of HCC. However, the pathogenesis underlying VM is complex and has not been fully defined. m6A is a common mRNA modification and has many biological effects. However, the relationship between m6A and VM remains unclear. In this research, we found that m6A methyltransferase METTL3 in HCC tissues was positively correlated with VM. The m6A level of mRNA significantly increased in 3D cultured cells treated with VEGFa and was related to VM formation. Transcriptome sequencing analysis of 3D cultured cells with knockdown Mettl3 showed that the Hippo pathway was involved in m6A-mediated VM formation. Further mechanism research indicated that the m6A modification of YAP1 mRNA affected the translation of YAP1 mRNA. In conclusion, m6A methylation plays a key role in VM formation in HCC. METTL3 and YAP1 could be potential therapeutic targets via impairing VM formation in anti-metastatic strategies.
引用
收藏
页码:83 / 96
页数:13
相关论文
共 551 条
  • [1] Villanueva A(2019)Hepatocellular carcinoma N Engl J Med 380 1450-1462
  • [2] Vogel A(2020)Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma Cancer Treat Rev 82 101946-1302
  • [3] Saborowski A(2019)YY1 promotes endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma by transcriptionally activating VEGFA Front Oncol 9 1187-953
  • [4] Yang W(2016)Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases Nat Med 22 1294-90
  • [5] Li Z(2017)Hypoxia-mediated mechanisms associated with antiangiogenic treatment resistance in glioblastomas Am J Pathol 187 940-752
  • [6] Qin R(2018)FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA Cancer Lett 439 78-361
  • [7] Wang X(1999)Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry Am J Pathol 155 739-3591
  • [8] An H(2019)VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression Cell Death Differ 26 348-1754
  • [9] Wang Y(2017)Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway J Cell Mol Med 21 3579-504
  • [10] Zhu Y(2018)Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition J Cell Mol Med 22 1743-1439